Advertisement
New Zealand markets close in 6 hours 53 minutes
  • NZX 50

    11,867.58
    -89.92 (-0.75%)
     
  • NZD/USD

    0.5935
    +0.0043 (+0.72%)
     
  • ALL ORDS

    7,831.90
    -100.10 (-1.26%)
     
  • OIL

    79.13
    +0.13 (+0.16%)
     
  • GOLD

    2,330.20
    +19.20 (+0.83%)
     

What Does Aehr Test Systems's (NASDAQ:AEHR) Share Price Indicate?

Aehr Test Systems (NASDAQ:AEHR), is not the largest company out there, but it saw a significant share price rise of over 20% in the past couple of months on the NASDAQCM. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today I will analyse the most recent data on Aehr Test Systems’s outlook and valuation to see if the opportunity still exists.

Check out our latest analysis for Aehr Test Systems

What Is Aehr Test Systems Worth?

Aehr Test Systems is currently expensive based on my price multiple model, where I look at the company's price-to-earnings ratio in comparison to the industry average. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 76.42x is currently well-above the industry average of 18.08x, meaning that it is trading at a more expensive price relative to its peers. But, is there another opportunity to buy low in the future? Given that Aehr Test Systems’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

What kind of growth will Aehr Test Systems generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. In Aehr Test Systems' case, its revenues over the next few years are expected to grow by 96%, indicating a highly optimistic future ahead. If expense does not increase by the same rate, or higher, this top line growth should lead to stronger cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? It seems like the market has well and truly priced in AEHR’s positive outlook, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe AEHR should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on AEHR for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for AEHR, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example, Aehr Test Systems has 4 warning signs (and 1 which is concerning) we think you should know about.

If you are no longer interested in Aehr Test Systems, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here